126
Participants
Start Date
April 27, 2020
Primary Completion Date
October 31, 2025
Study Completion Date
December 31, 2025
CX1003
Oral dose A 4-day single dose period, followed by a period of daily-dose in continuous 28-day treatment cycle (the 1st cycle) or 21-day treatment cycles (the 2nd cycle and beyond) Dosage range: 25 mg, 50mg, 75mg, 100mg,125mg,150mg,175mg
RECRUITING
National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing
Chinese Academy of Medical Sciences
OTHER
West China Hospital
OTHER
Beijing Tongren Hospital
OTHER
Beijing Konruns Pharmaceutical Co., Ltd.
INDUSTRY